Vaxart, Inc. Income (Loss) from Continuing Operations, Per Basic Share
Vaxart, Inc. (VXRT) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.12 per share for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2012-11-08
- Vaxart, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2012-09-30 was -$0.12.
- Vaxart, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2012-06-30 was -$0.06.
- Vaxart, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2012-03-31 was -$0.03, a 160.00% decline year-over-year.
- Vaxart, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2011-09-24 was -$0.07, a 158.33% decline year-over-year.
- Vaxart, Inc. income (loss) from continuing operations, per basic share for fiscal 2011 was -$0.18, a 1000.00% decline from fiscal 2010.
- Vaxart, Inc. income (loss) from continuing operations, per basic share for fiscal 2010 was $0.02.
- Vaxart, Inc. income (loss) from continuing operations, per basic share for fiscal 2009 was -$0.37.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|
| 2012-09-30 | -$0.12 10-Q · filed 2012-11-08 | -$0.21 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | -$0.06 10-Q · filed 2012-08-09 | -$0.10 10-Q · filed 2012-08-09 | ||
| 2012-03-31 | -$0.03 10-Q · filed 2012-05-10 | |||
| 2011-12-31 | -$0.18 10-K · filed 2012-03-14 | |||
| 2011-09-24 | -$0.07 10-Q · filed 2012-11-08 | -$0.13 10-Q · filed 2012-11-08 | ||
| 2011-06-25 | -$0.11 10-Q · filed 2012-08-09 | -$0.06 10-Q · filed 2012-08-09 | ||
| 2011-03-26 | $0.05 10-Q · filed 2012-05-10 | |||
| 2010-12-25 | $0.02 10-K · filed 2012-03-14 | |||
| 2010-09-25 | $0.12 10-Q · filed 2011-11-02 | $0.16 10-Q · filed 2011-11-02 | ||
| 2009-12-26 | -$0.37 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |